
|Articles|November 3, 2021
THREAD Acquires Modus Outcomes
Advertisement
THREAD has acquired Modus Outcomes. Headquartered in Cambridge, Mass., Modus Outcomes is a research consultancy that supports the design and selection of electronic clinical outcome assessments (eCOA), participant-focused trial design and scientific delivery of DCTs.
With this acquisition, THREAD will bring together its eCOA technology platform with Modus' services. Modus brings to THREAD:
- Knowledge in qualitative research, advanced psychometric analysis and biostatistics
- Consulting capabilities specializing in patient-centered outcomes strategies, including instrument design/selection and regulatory support
- Outcomes researchers and company partners, Dr. Patrick Marquis, CEO, Dr. Stefan Cano, chief scientific officer, and Dr. Antoine Regnault, global lead, Statistics
- A team of 40 holding an array of certifications and specializations
- Offices in London and Lyon, France
Financial details of the acquisition are not being disclosed.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
2
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
3
Accelerate Clinical Trials with AI-Enhanced Financial Management
4
SCOPE Summit 2026 Keynote Fireside Chat: Aligning Purpose, Innovation, and Operational Excellence in Clinical Development
5




